Baltic Atherosclerosis Conference 2021

03.12.2021 - 04.12.2021 Tallinn, Estonia

Speakers and Chairpersons

First Name	Surname	Date	Presentation or session title
Margus	Viigimaa	2021-12-03 09:30 -09:45	Opening of the conference
Dovilė	Karčiauskaitė	2021-12-04 10:00 -11:30	Update about laboratory diagnostics of atherosclerosis risk
Žaneta	Petrulionienė	2021-12-03 14:15 -15:45	S3 - Future of dyslipidemia treatment is today: siRNA in theory and practice
Anu	Hedman	2021-12-03 16:05 -17:05	S4 - Prevention of atherosclerosis and heart failure in patients with type 2 diabetes
Gustavs	Latkovskis	2021-12-03 11:45 -13:15	S2 - Early atherosclerosis, hypertension and personalised prevention
Kārlis	Trušinskis	2021-12-03 14:15 -15:45	Discussion and Q&A
François	Mach	2021-12-03 09:45 -11:15	Aggressive combination treatment following the dyslipidemia guidelines
Anu	Hedman	2021-12-03 16:05 -17:05	HF with reduced EF in diabetics: a double trouble
Kārlis	Trušinskis	2021-12-04 10:00 -11:30	S6 - Advances in atherosclerosis diagnostics
Andrei	Šamarin	2021-12-04 10:00 -11:30	Imaging of the coronary plaque vulnerability using CTA
Kairit	Joost	2021-12-04 10:00 -11:30	Advances in genetic testing of familial hypercholesterolemia
Žaneta	Petrulionienė	2021-12-03 14:15 -15:45	The gap between dyslipidemia guidelines and clinical practice: causes and possible solutions
Evija	Knoka	2021-12-03 11:45 -13:15	Genetics and atherosclerotic plaque composition. Is there a link?
Žaneta	Petrulionienė	2021-12-03 14:15 -15:45	Session closing
Margus	Viigimaa	2021-12-03 17:45 -18:00	Wrap-up and Concluding Remarks of the 1st Day
Margus	Viigimaa	2021-12-03 16:05 -17:05	S4 - Prevention of atherosclerosis and heart failure in patients with type 2 diabetes
		2021-12-04 11:45 -12:50	Discussion
Margus	Viigimaa	2021-12-03 09:45 -11:15	Panel discussion
Margus	Viigimaa	2021-12-03 16:05 -17:05	Introduction
Gustavs	Latkovskis	2021-12-04 11:45 -12:50	S7 - Familial hypercholesterolemia registries in Baltic countries
Kārlis	Trušinskis	2021-12-03 14:15 -15:45	First clinical experience with inclisiran
		2021-12-03 16:05 -17:05	Discussion
Rimvydas	Šlapikas	2021-12-03 17:05 -17:45	S5 - Atherosclerosis and ESC 2021 CVD Prevention guidelines
Margus	Viigimaa	2021-12-03 09:45 -11:15	Aggressive combination treatment post MI
Margus	Viigimaa	2021-12-03 14:15 -15:45	Welcome
Žaneta	Petrulionienė	2021-12-03 14:15 -15:45	Discussion and Q&A
Andrejs	Ērglis	2021-12-03 17:05 -17:45	S5 - Atherosclerosis and ESC 2021 CVD Prevention guidelines
Iveta	Mintāle	2021-12-03 17:05 -17:45	S5 - Atherosclerosis and ESC 2021 CVD Prevention guidelines
Žaneta	Petrulionienė	2021-12-04 11:45 -12:50	FH registries in Baltic countries - Lithuania
Mikk	Jürisson	2021-12-03 11:45 -13:15	Personal prevention of CV diseases
Žaneta	Petrulionienė	2021-12-04 11:45 -12:50	Management of FH: an update about FH registries in the world
Ulrich	Laufs	2021-12-03 14:15 -15:45	Discussion and Q&A
Kārlis	Trušinskis	2021-12-03 11:45 -13:15	S2 - Early atherosclerosis, hypertension and personalised prevention
Rimvydas	Šlapikas	2021-12-03 11:45 -13:15	S2 - Early atherosclerosis, hypertension and personalised prevention
Žaneta	Petrulionienė	2021-12-03 14:15 -15:45	Welcome
		2021-12-04 10:00 -11:30	Discussion
Margus	Viigimaa	2021-12-03 09:45 -11:15	S1 - Aggressive combination treatment of dyslipidemias
Gustavs	Latkovskis	2021-12-04 11:45 -12:50	FH registries in Baltic countries - Latvia
Margus	Viigimaa	2021-12-03 14:15 -15:45	Session closing
Martin	Serg	2021-12-04 12:50 -13:00	Wrap-up and Concluding Remarks of the 2nd Day and Whole Conference 💝
Laima	Caunīte	2021-12-03 11:45 -13:15	Lessons learned from Latvian Early Atherosclerosis registry
Dovilė	Karčiauskaitė	2021-12-04 10:00 -11:30	S6 - Advances in atherosclerosis diagnostics
Martin	Serg	2021-12-04 11:45 -12:50	FH registries in Baltic countries - Estonia
Gustavs	Latkovskis	2021-12-03 09:45 -11:15	Aggressive combination treatment in FH patients
Annika	Adoberg	2021-12-03 11:45 -13:15	Atherosclerosis - The Cunning Attack of Chronic Kidney Disease
Margus	Viigimaa	2021-12-03 09:45 -11:15	Introduction
Gustavs	Latkovskis	2021-12-03 09:30 -09:45	Opening of the conference
Žaneta	Petrulionienė	2021-12-03 09:30 -09:45	Opening of the conference
François	Mach	2021-12-03 09:45 -11:15	S1 - Aggressive combination treatment of dyslipidemias
		2021-12-03 17:05 -17:45	Discussion
Gustavs	Latkovskis	2021-12-03 09:45 -11:15	Panel discussion
Sergei	Nazarenko	2021-12-04 10:00 -11:30	S6 - Advances in atherosclerosis diagnostics
Rimvydas	Šlapikas	2021-12-03 17:05 -17:45	Updated CV prevention in the ESC 2021 CVD Prevention guidelines
Martin	Serg	2021-12-04 11:45 -12:50	S7 - Familial hypercholesterolemia registries in Baltic countries
Kārlis	Trušinskis	2021-12-04 10:00 -11:30	What's hidden behind yellow pixel? From vulnerable plaque to vulnerable patient
François	Mach	2021-12-03 09:45 -11:15	Panel discussion
Margus	Viigimaa	2021-12-04 12:50 -13:00	Wrap-up and Concluding Remarks of the 2nd Day and Whole Conference 💝
Ulrich	Laufs	2021-12-03 14:15 -15:45	SiRNA in theory and practice
Margus	Viigimaa	2021-12-03 09:30 -09:45	Introduction
Margus	Viigimaa	2021-12-04 12:50 -13:00	Conference Wrap-up
Gustavs	Latkovskis	2021-12-03 16:05 -17:05	Interpretation of HFpEF data in type 2 diabetic patients
Žaneta	Petrulionienė	2021-12-04 11:45 -12:50	S7 - Familial hypercholesterolemia registries in Baltic countries
Margus	Viigimaa	2021-12-03 14:15 -15:45	S3 - Future of dyslipidemia treatment is today: siRNA in theory and practice
		2021-12-03 11:45 -13:15	Discussion
Margus	Viigimaa	2021-12-03 14:15 -15:45	Discussion and Q&A
First Name	Surname	Date	Presentation or session title